| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Childhood Germ Cell Tumor | |||||
| Extragonadal Germ Cell Tumor | |||||
| Testicular Germ Cell Tumor | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasms, Germ Cell and Embryonal | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Interventions listed in this trial | ||||
| bleomycin | |||||
| carboplatin | |||||
| cisplatin | |||||
| cyclophosphamide | |||||
| etoposide | |||||
| filgrastim | |||||
| conventional surgery | |||||
| radiation therapy | |||||
| 5 | More general drug interventions related to this trial | ||||
| Alkylating Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Alkylating | |||||
| Antirheumatic Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Myeloablative Agonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Memorial Sloan-Kettering Cancer Center | |||||
| National Cancer Institute (NCI) | |||||
| Eastern Cooperative Oncology Group | |||||
| Southwest Oncology Group | |||||
| Cancer and Leukemia Group B | |||||
|
